Dalfampridine
NDC 16729-292, Dalfampridine, tablet, film coated, extended release, from Accord Healthcare Inc..
- Product NDC
- 16729-292
- Status
- Listed
- Labeler
- Accord Healthcare Inc.
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206863
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16729-292 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DALFAMPRIDINE10 mg/1
Pharmacologic classes
Potassium Channel Antagonists [MoA]; Potassium Channel Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16729-292-12 | 16729029212 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (16729-292-12) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/354a97e8-35c8-418b-91b2-9e8e066cec65NADAC price for package 16729029212
GET /v1/drugs/nadac/16729029212
Use it
Look up 16729-292 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16729-292 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16729-292. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.